FGEN 0.98 (-8.41%)
US31572Q8087BiotechnologyBiotechnology

FibroGen (FGEN) Financial Metrics

This table shows a selected set of financial data points of FibroGen (FGEN). You can choose which elements to display by selecting the desired chart and column.

MarketCap

Total Revenue

Free CashFlow

Year EPS Dividend Yield PE Ratio MarketCap Return On Assets Total Revenue Free CashFlow EBITDA Net Income Cash
2022 -3.12 0 -5.14 1.51B -0.42 140.73M -184.67M -282.83M -293.65M 155.7M
2021 -3.13 0 -4.51 1.31B -0.36 235.31M -112.42M -273.72M -290.02M 171.22M
2020 -2.11 0 -17.61 3.33B -0.22 176.32M 77.61M -164.28M -189.29M 678.39M
2019 -0.89 0 -48.27 3.72B -0.09 256.58M -84.47M -73.77M -76.97M 126.27M
2018 -1.03 0 -45.02 3.89B -0.1 212.96M -84.16M -68.56M -86.42M 89.26M
2017 -1.73 0 -27.41 3.46B -0.18 125.67M -75.01M -110.08M -126.2M 673.66M
2016 -0.98 0 -21.77 1.34B -0.13 179.58M 5.86M -44.99M -61.68M 173.78M
2015 -1.42 0 -21.43 1.84B -0.18 180.83M -20.55M -68.83M -85.78M 153.32M
2014 -3.17 0 -8.63 513.31M -0.15 137.6M 14.3M -43.93M -59.5M 165.46M
2013 -0.32 0 0 0 -0.05 102.17M 19.11M 843K -14.94M 76.33M
2012 -0.69 0 0 0 0 65.93M -6.35M -17.05M -32.57M 38.87M

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.